1. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
   Tianxiang Chen et al, 2021, Cell Death & Disease CrossRef
2. LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer
   Zeguo Sun et al, 2022, Molecular Cancer CrossRef
3. Comprehensive Analysis of Differential Gene Expression Profile via RNA Sequencing in the Human Ovarian Cancer SKOV3 Cells Treated with Simvastatin
   Qianyu Liu et al, 2022, Chemical Research in Chinese Universities CrossRef
4. hsa-miR-875-5p inhibits tumorigenesis and suppresses TGF-β signalling by targeting USF2 in gastric cancer
   Shenshuo Gao et al, 2022, Journal of Translational Medicine CrossRef
5. Pathway-Based Drug Repurposing with DPNetinfer: A Method to Predict Drug–Pathway Associations via Network-Based Approaches
   Jiye Wang et al, 2021, Journal of Chemical Information and Modeling CrossRef
6. Statins Lower Lipid Synthesis But Promote Secretion of Cholesterol-Enriched Extracellular Vesicles and Particles
   Yundi Chen et al, 2022, Frontiers in Oncology CrossRef
7. HIF-1α-activated TMEM237 promotes hepatocellular carcinoma progression via the NPHP1/Pyk2/ERK pathway
   Tianxiang Chen et al, 2023, Cellular and Molecular Life Sciences CrossRef
8. In-situ formed thermosensitive hydrogel amplifies statin-mediated immune checkpoint blockade for coordinated tumor chemo-immunotherapy
   Zefan Liu et al, 2023, Frontiers in Pharmacology CrossRef
9. Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma
   Xiang-Di Tan et al, 2024, Journal of Chemotherapy CrossRef
10. Statins and hearing
    Donna S. Whitlon, 2022, Hearing Research CrossRef